Sign in

CIK 0000744218 · Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133191702
Phone
908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. UPLOAD Other SEC-generated Letter
  8. CT ORDER Other Confidential Order
  9. DEF 14A Proxy Proxy Statement
  10. PRE 14A Proxy Proxy Statement (Preliminary)
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. 8-K Event Executive or director change
  14. 8-K Event Executive or director change
  15. CT ORDER Other Confidential Order
  16. SC 13D/A Stake Beneficial Ownership Report
  17. 4 Insider Changes in Ownership
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. 8-K Event Auditor change
  20. 8-K Event Other events

Page 47 of 65 · 1,298 filings